0001209191-23-011245.txt : 20230221
0001209191-23-011245.hdr.sgml : 20230221
20230221165808
ACCESSION NUMBER: 0001209191-23-011245
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230216
FILED AS OF DATE: 20230221
DATE AS OF CHANGE: 20230221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Millar Kerri-Ann
CENTRAL INDEX KEY: 0001739126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 23649177
MAIL ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-16
0
0001645460
Cue Biopharma, Inc.
CUE
0001739126
Millar Kerri-Ann
C/O CUE BIOPHARMA INC.
40 GUEST STREET
BOSTON
MA
02135
0
1
0
0
CHIEF FINANCIAL OFFICER
Stock Option (right to buy)
3.21
2023-02-16
4
A
0
124000
0.00
A
2033-02-15
Common Stock
124000
124000
D
This stock option becomes exercisable in eight equal semi-annual installments beginning on August 16, 2023.
/s/ Kerri-Ann Millar by Colin Sandercock, attorney-in-fact
2023-02-21